|
Volumn 12, Issue 6, 2007, Pages 643-644
|
Efficacy of Lansap® combination therapy for eradication of H. pylori [2]
|
Author keywords
Combination package; Eradication; H. pylori
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLARITHROMYCIN PLUS LANSOPRAZOLE;
ANTIBIOTIC AGENT;
CLARITHROMYCIN;
LANSAP;
LANSOPRAZOLE;
UNCLASSIFIED DRUG;
ANTIINFECTIVE AGENT;
CHRONIC GASTRITIS;
DIARRHEA;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DUODENUM ULCER;
ENDOSCOPY;
ERADICATION THERAPY;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
LETTER;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SOFT STOOL;
STOMACH POLYP;
STOMACH ULCER;
UREA BREATH TEST;
ADOLESCENT;
ADULT;
AGED;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
HELICOBACTER PYLORI;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
|
EID: 36249021471
PISSN: 10834389
EISSN: 15235378
Source Type: Journal
DOI: 10.1111/j.1523-5378.2007.00555.x Document Type: Letter |
Times cited : (7)
|
References (4)
|